2020ASCO肺癌摘要汇总9502.pptx

下载文档 降价啦

9
0
约小于1千字
约 23页
2020-07-21 发布于山东
举报
版权申诉
保障服务

2020ASCO肺癌摘要汇总9502.pptx

1、本文档共23页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

Slide 1;Introduction;CCTG BR.34 Schema;Objectives;Statistical Considerations;Patient Disposition;Patient Characteristics (1);Patient Characteristics (2);Overall Survival by Treatment Arm;Overall Survival in Pre-specified Subgroups;Anti Cancer Therapy After Progression;Progression-Free Survival;Progression-Free Survival in Pre-specified Subgroups;Objective Response Rate;Treatment Effects on OS, PFS in Pre-specified bTMB, Tumour PD-L1 TC Subgroups;Overall Survival by Treatment Arm: bTMB;Progression Free Survival: bTMB;Risk of Death and Progression: <br />Combined b-TMB and PD-L1 TC Subgroups;Adverse Events (AE);Selected Adverse Events (deemed possibly, probably, definitely attributed to protocol therapy) reported in ≥10% of patients ;Adverse Events of Special Interest (deemed possibly, probably, definitely attributed to protocol therapy);Conclusions;Acknowledgements